产品名称 | NebuSelect™ Recombinant Human LRIG1, His-tag |
---|---|
目录号 | NBL-242331 |
别名 | LRIG1; LIG-1; LIG1; LRIG1; D6Bwg0781e; Img |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q96JA1-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242331-100ug | 100ug | Inquire | Inquire | |
NBL-242331-1mg | 1mg | Inquire | Inquire | |
NBL-242331-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human LRIG1, His-tag
Catalog#:
NBL-242331
Description:
NebuSelect™ Recombinant Human LRIG1, His-tag(Cat#NBL-242331) is expressed in HEK293 with His tag at the C-Terminus.It contains Ala35-Ser779.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 83 kDa. Due to glycosylation, the protein migrates to 85-105 kDa based on Bis-Tris PAGE result.
Target Name:
LRIG1; LIG-1; LIG1; LRIG1; D6Bwg0781e; Img
Target Information:
The leucine-rich repeats and immunoglobulin-like domains (LRIG)-1 is a tumor suppressor gene that belongs to the LRIG family. LRIG1 expression has prognostic significance in various human cancers. Somatic mutations, which are associated with a certain rate of response to targeted therapies, are ubiquitously found in human non-small cell lung cancer (NSCLC). LRIG1 was an independent prognostic factor for OS of NSCLC patients. LRIG1 in combination with other clinicopathological risk factors was a stronger prognostic model than clinicopathological risk factors alone.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.